Endocyte Inc (ECYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,204 | -9,770 | -40,532 | -29,778 | -17,708 |
| Depreciation Amortization | 322 | 81 | 606 | 391 | 244 |
| Accounts receivable | -4,676 | 357 | N/A | N/A | -122 |
| Accounts payable and accrued liabilities | -819 | 67 | 943 | 1,302 | 1,083 |
| Other Working Capital | 109,943 | -1,295 | 2,714 | 3,520 | 2,896 |
| Other Operating Activity | 8,067 | 434 | 1,684 | 649 | 290 |
| Operating Cash Flow | $97,635 | $-10,126 | $-34,585 | $-23,916 | $-13,318 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -685 | -177 | -235 | -199 | -41 |
| Purchase Of Investment | -180,882 | -42,748 | -236,930 | -193,561 | -151,253 |
| Sale Of Investment | 102,567 | 93,413 | 169,854 | 121,157 | 96,999 |
| Investing Cash Flow | $-79,000 | $50,489 | $-67,311 | $-72,603 | $-54,296 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 3,591 | 3,591 | 3,591 |
| Debt Repayment | -13,544 | N/A | -2,708 | -2,708 | -1,337 |
| Common Stock Issued | 209 | 115 | 145,498 | 145,405 | 78,210 |
| Financing Cash Flow | $-13,335 | $115 | $146,381 | $146,288 | $80,463 |
| Exchange Rate Effect | 1 | 2 | -6 | -1 | N/A |
| Beginning Cash Position | 61,353 | 61,353 | 16,873 | 16,873 | 16,873 |
| End Cash Position | 66,654 | 101,832 | 61,353 | 66,641 | 29,723 |
| Net Cash Flow | $5,301 | $40,480 | $44,480 | $49,768 | $12,850 |
| Free Cash Flow | |||||
| Operating Cash Flow | 97,635 | -10,126 | -34,585 | -23,916 | -13,318 |
| Capital Expenditure | -685 | -177 | -235 | -199 | -41 |
| Free Cash Flow | 96,950 | -10,303 | -34,820 | -24,115 | -13,359 |